Generate a tailored SOP for Dr. Gerrit Meijer. Improve your application with a focused, well-structured draft.
Gerrit Meijer is a Full Professor at UMC Utrecht, specializing in personalized medicine and translational research. He has held significant leadership roles, including National Director of EATRIS-NL since 2019 and Vice Chair of the Personalized Medicine Program Committee at ZonMW since 2014. Meijer also served as National Node Director of BBMRI-NL and is an active member of several committees, including the AACR Publications Committee and the Education Training Committee. His work extends to various advisory roles, such as participating in the External Advisory Committee of the IPO Porto Research Center and the Scientific Advisory Board of the German Medical Informatics Initiative. Meijer has co-founded CRCbioscreen and received the James S. Ewing-Thelma B. Dunn Award for Outstanding Achievement in Pathology from the Cancer Research Committee in 2022. He has been involved in the editorial board of Cellular Oncology since 2012, demonstrating his commitment to advancing cancer research and pathology. Through his extensive contributions, Meijer plays a crucial role in shaping the field of personalized medicine in the Netherlands.
EATRIS-NL • Utrecht, Netherlands
Oversees the strategic direction and implementation of personalized medicine initiatives.
Personalized Medicine Program Committee, ZonMW • Utrecht, Netherlands
Contributes to the development and evaluation of personalized medicine projects.
PhD candidates at UMC Utrecht are generally considered employees. Admission requires first securing a position with a professor (promotor) within the Graduate School of Life Sciences.